Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 36, Issue 1, Pages 100-107
Publisher
Wiley
Online
2015-05-26
DOI
10.1111/liv.12878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification
- (2015) David J. Pinato et al. Clinical Gastroenterology and Hepatology
- Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma
- (2015) Jin-Ping Lai et al. HISTOPATHOLOGY
- Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
- (2015) Beom Kyung Kim et al. JOURNAL OF HEPATOLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Net Reclassification Improvement: Computation, Interpretation, and Controversies
- (2014) Maarten J.G. Leening et al. ANNALS OF INTERNAL MEDICINE
- LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions
- (2014) Donald G. Mitchell et al. HEPATOLOGY
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
- (2013) Yong Kang Lee et al. BMC CANCER
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
- (2013) Wolfgang Sieghart et al. HEPATOLOGY
- Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization
- (2013) Eun Sun Jang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE
- (2013) Florian Hucke et al. JOURNAL OF HEPATOLOGY
- Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
- (2013) Sangheun Lee et al. PLoS One
- Number of Target Lesions for EASL and Modified RECIST to Predict Survivals in Hepatocellular Carcinoma Treated with Chemoembolization
- (2012) B. K. Kim et al. CLINICAL CANCER RESEARCH
- Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
- (2012) Beom Kyung Kim et al. EUROPEAN JOURNAL OF CANCER
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
- (2011) Hwi Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma
- (2011) Myoung Ha Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
- (2010) Alejandro Forner et al. SEMINARS IN LIVER DISEASE
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation